{"schema_version":"secwatch.filing_event.v1","accession":"0000926617-23-000050","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2023-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.895693+00:00","generated_at":"2026-06-15T00:24:40.492582+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aspira Women's Health appoints Torsten Hombeck as CFO, effective June 15, 2023","bullets":["Torsten Hombeck, Ph.D., named CFO; previously CFO of Akari Therapeutics.","Annual base salary of $325,000 with bonus eligibility up to 50% of base.","Initial stock option grant of 13,333 shares, vesting 33.3% annually over 3 years.","Severance: 6 months base salary and COBRA if terminated without cause or resigns for good reason.","Subject to 12-month non-compete and non-solicitation covenants."],"urls":{"canonical":"https://secwatch.observer/filing/0000926617-23-000050","json":"https://secwatch.observer/filing/0000926617-23-000050.json","markdown":"https://secwatch.observer/filing/0000926617-23-000050.md","text":"https://secwatch.observer/filing/0000926617-23-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000050/0000926617-23-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000050/awh-20230516x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:24:40.492582+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"500a17215c","claim":"Torsten Hombeck was appointed as Chief Financial Officer at Aspira Women's Health Inc..","evidence_excerpt":"appointed Tortsten Hombeck, Ph.D. as the Company’s Chief Financial Officer, effective as of June 15, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000092661723000050/0000926617-23-000050-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}